Researched effects In a diet-induced-obese mouse study (Neelakantan et al., Biochemical Pharmacology, 2018), subcutaneous 5-Amino-1MQ (20 mg/kg, three times daily, roughly 11 days) produced about 5.1% body-weight loss versus continued weight gain in untreated controls, roughly 35% less epididymal white fat mass, smaller adipocytes, lower plasma cholesterol, and improved glucose tolerance, with no reported change in food intake and no observed adverse effects in the mice
Start cagrilintide first, reach at least the 0.5 mg dose, then begin semaglutide titration
Potential Implications: The peptides efficacy in healing gastrointestinal fistulas and anastomoses suggests potential therapeutic applications in related conditions
This is why you have to work with your physician that understands the use of these peptides so you dont get into issues like that